Acetoxyacetyl chloride → 5-(3-(azetidin-1-yl)-3-oxopropyl)-1'-(2-hydroxyacetyl)-N-(5-methylthiazol-2-yl)spiro[indoline-3,3'-pyrrolidine]-1-carboxamide
Reaction equation
C(O[C:4](=[O:36])[CH2:5][CH2:6][C:7]1[CH:8]=[C:9]2[C:15]3([CH2:19][CH2:18][N:17]([C:20]([O:22]C(C)(C)C)=O)[CH2:16]3)[CH2:14][N:13]([C:27]([O:29]CC[Si](C)(C)C)=O)[C:10]2=[CH:11][CH:12]=1)C.[NH2:37][C:38]1[S:39][C:40]([CH3:43])=[CH:41][N:42]=1.C(OC[C:49](Cl)=[O:50])(=O)C.Cl.[NH:53]1[CH2:56][CH2:55][CH2:54]1>>[N:53]1([C:4](=[O:36])[CH2:5][CH2:6][C:7]2[CH:8]=[C:9]3[C:15]4([CH2:19][CH2:18][N:17]([C:20](=[O:22])[CH2:49][OH:50])[CH2:16]4)[CH2:14][N:13]([C:27]([NH:37][C:38]4[S:39][C:40]([CH3:43])=[CH:41][N:42]=4)=[O:29])[C:10]3=[CH:11][CH:12]=2)[CH2:56][CH2:55][CH2:54]1Participants
5
Reactant 4
Product 1
Procedure
The captioned compound was obtained in the form of a white solid by performing the same reactions and/or treatments as those in Step 5 of Example 383, and Examples 1, 2, 3, 29, and 85, with the exceptions that 1-(2-(trimethylsilyl)ethyl) 1′-tert-butyl 5-(3-ethoxy-3-oxopropyl)spiro[indoline-3,3′-pyrrolidine]-1,1′-dicarboxylate was used instead of 1-(2-(trimethylsilyl)ethyl) 1′-tert-butyl 5-(methylsulfonyl)spiro[indoline-3,3′-pyrrolidine]-1,1′-dicarboxylate, that 2-amino-5-methylthiazole was used instead of 2-amino-5-chlorothiazole hydrochloride, that acetoxyacetyl chloride was used instead of acetyl chloride, and that azetidine hydrochloride was used instead of dimethylamine hydrochloride.
Workup
- customThe captioned compound was obtained in the form of a white solid
Sources & evidence
- ORD record
- ord-711b1c63ef4343b286c209bd48c29bb3
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08921576B2
Reaction notes
Loading…